Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MILEI is a German dairy and nutrition ingredients manufacturer focused on the enrichment and fractionation of valuable components from milk and whey. The company produces functional ingredients including lactoferrin, whey protein concentrates and isolates, lactose, and related milk-derived ingredients used in infant formula, supplements, sports nutrition, and clinical nutrition. Founded in 1972 and headquartered in Leutkirch, Germany, MILEI operates as part of the Morinaga Milk Group and serves customers internationally. While it is not a therapeutic biotech or pharma developer, it is healthcare-adjacent through its role in nutritional and functional ingredients for health-focused end markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MILEI.